In a groundbreaking decision, our country has approved the access of hallucinogenic mushrooms for medical purposes. People suffering by mental health illnesses, including depression and nervousness, can potentially obtain therapy through regulated clinics. This policy represents a major change in Canada's approach to mental healthcare and reflects